DB18664ExperimentalGene Therapies
BGT-DTDS is an investigational gene therapy comprising an adeno-associated viral vector type 2 (AAV2) encoding the human SLC6A3 gene. It is under investigation for the treatment of dopamine transporter deficiency...
- Code names
- BGT DTDS
Which companies are running trials of BGT-DTDS, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account